Page last updated: 2024-10-22

acetaminophen and Charcot-Marie-Tooth Disease, Demyelinating, Type 4f

acetaminophen has been researched along with Charcot-Marie-Tooth Disease, Demyelinating, Type 4f in 1 studies

Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, X1
Hua, S1
Deng, J1
Du, Z1
Zhang, D1
Liu, Z1
Khan, NU1
Zhou, M1
Chen, Z1

Other Studies

1 other study available for acetaminophen and Charcot-Marie-Tooth Disease, Demyelinating, Type 4f

ArticleYear
Astaxanthin Activated the Nrf2/HO-1 Pathway to Enhance Autophagy and Inhibit Ferroptosis, Ameliorating Acetaminophen-Induced Liver Injury.
    ACS applied materials & interfaces, 2022, Sep-28, Volume: 14, Issue:38

    Topics: Acetaminophen; Acetylcysteine; Autophagy; Chemical and Drug Induced Liver Injury; Chemical and Drug

2022